Global Radiodermatitis Market

Radiodermatitis Comprehensive Study by Type (Topical (Corticosteroids, Hydrophilic Creams, and Antibiotics), Oral Medication (Corticosteroids, Oral Analgesics, and Antibiotics), Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, and Silicone Coated Dressing), Others (GM-CSF gauze, silver leaf dressing, etc.)), Application (Retail Pharmacies, Hospital Pharmacy, Online stores), Therapy (Radiation Therapy, Proton Therapy), Severity (Grade 1, Grade 2, Grade 3, Grade 4) Players and Region - Global Market Outlook to 2026

Radiodermatitis Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 3.93%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is RadiodermatitisMarket?
As the cases of Cancer escalate across the world, the demand in the Global Radiodermatitis is anticipated to propel the market growth. Cancer patients are more likely to develop radiation-induced dermatitis owing to frequent radiation treatments. Radiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions and has a significant negative impact on a patient’s physical functionalities and quality of life. It has been estimated that in developed countries, nearly half of the patients who receive treatment for cancer are subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. Radiodermatitis is a side effect of external beam ionizing radiation caused by radiotherapy for underlying malignancies. Development and severity of radiodermatitis are associated with multiple patient and treatment factors such as total radiation dose, duration of radiotherapy, and treatment with chemotherapy.

Market Trend
High Disposable income and the presence of Sophisticated Healthcare Infrastructure and Rise in the adoption of radiotherapy procedures, and surge in the number of awareness campaigns about the treatment of radiodermatitis.

Market Drivers
Owing to Increased Disposable Income among Urban Populations, Improving Healthcare Infrastructure in Several Emerging Economies leading to a large number of the pool of patients, Growth in the number of cancer patients and Increase in the geriatric population

Opportunities
More and more R&D investment by the Government, deployed by global players and The increasing number of organizations formed to enhance public awareness pertaining to proper management and prevention of radiation dermatitis.

The Players Covered in the Study are:
3M Healthcare (United States), Acelity L.P Inc. (United States), Molnlycke Health Care (Sweden), Smith & Nephew PLC (United Kingdom), Conva Tec Group, PLC (United Kingdom), BMG Pharma (Italy), Alliqua Biomedical Inc. (United States) and Intermed Pharmaceuticals (India)

Available Customization:
List of players that can be included in the study on immediate basis are Stratpharma AG (Switzerland).

Report Objectives / Segmentation Covered

By Type
  • Topical (Corticosteroids, Hydrophilic Creams, and Antibiotics)
  • Oral Medication (Corticosteroids, Oral Analgesics, and Antibiotics)
  • Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, and Silicone Coated Dressing)
  • Others (GM-CSF gauze, silver leaf dressing, etc.)
By Application
  • Retail Pharmacies
  • Hospital Pharmacy
  • Online stores
By Therapy
  • Radiation Therapy
  • Proton Therapy

By Severity
  • Grade 1
  • Grade 2
  • Grade 3
  • Grade 4

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Owing to Increased Disposable Income among Urban Populations
      • 3.2.2. Improving Healthcare Infrastructure in Several Emerging Economies leading to a large number of the pool of patients
      • 3.2.3. Growth in the number of cancer patients
      • 3.2.4. Increase in the geriatric population
    • 3.3. Market Challenges
      • 3.3.1. High cost factors associated with the treatment of Radiodermatitis treatment regimen is posing a challenge for the market.
    • 3.4. Market Trends
      • 3.4.1. High Disposable income and the presence of Sophisticated Healthcare Infrastructure
      • 3.4.2. Rise in the adoption of radiotherapy procedures, and surge in the number of awareness campaigns about the treatment of radiodermatitis.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Radiodermatitis, by Type, Application, Therapy, Severity and Region (value) (2015-2020)
    • 5.1. Introduction
  • 6. Radiodermatitis: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. 3M Healthcare (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Acelity L.P Inc. (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Molnlycke Health Care (Sweden)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Smith & Nephew PLC (United Kingdom)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Conva Tec Group, PLC (United Kingdom)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. BMG Pharma (Italy)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Alliqua Biomedical Inc. (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Intermed Pharmaceuticals (India)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
  • 7. Global Radiodermatitis Sale, by Type, Application, Therapy, Severity and Region (value) (2021-2026)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Research Programs/Design for This Report
  • Table 10. Key Data Information from Secondary Sources
  • Table 11. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. 3M Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 5. 3M Healthcare (United States) Revenue: by Geography 2020
  • Figure 6. Acelity L.P Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 7. Acelity L.P Inc. (United States) Revenue: by Geography 2020
  • Figure 8. Molnlycke Health Care (Sweden) Revenue, Net Income and Gross profit
  • Figure 9. Molnlycke Health Care (Sweden) Revenue: by Geography 2020
  • Figure 10. Smith & Nephew PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 11. Smith & Nephew PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 12. Conva Tec Group, PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 13. Conva Tec Group, PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 14. BMG Pharma (Italy) Revenue, Net Income and Gross profit
  • Figure 15. BMG Pharma (Italy) Revenue: by Geography 2020
  • Figure 16. Alliqua Biomedical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Alliqua Biomedical Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Intermed Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 19. Intermed Pharmaceuticals (India) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • 3M Healthcare (United States)
  • Acelity L.P Inc. (United States)
  • Molnlycke Health Care (Sweden)
  • Smith & Nephew PLC (United Kingdom)
  • Conva Tec Group, PLC (United Kingdom)
  • BMG Pharma (Italy)
  • Alliqua Biomedical Inc. (United States)
  • Intermed Pharmaceuticals (India)
Additional players considered in the study are as follows:
Stratpharma AG (Switzerland)
Select User Access Type

Key Highlights of Report


Jun 2021 220 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Radiodermatitis Market Quantitative research analysis
Global Radiodermatitis Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Radiodermatitis Market Report?

Have a Query? Click Here

Other Related Reports

Telecommunications Relay Service Comprehensive Study by Type (Text-to-Voice TTY-based TRS, Speech-to-Speech Relay Service, Captioned Telephone Service, IP Captioned Telephone Service, Internet Protoc...
$ 3800
Telecom Order Management Comprehensive Study by Network Type (Wireline, Wireless), Service (Integration and Installation Services, Consulting Services, Support Services, Others), Deployment Type (On...
$ 3750
Emotion Analytics Comprehensive Study by Type (Facial Analytics, Speech Analytics, Video Analytics, Others), Application (Media & Entertainment, Retail and Education, Financial Services, Healthcare, ...
$ 3800
Plastic Components Comprehensive Study by Type (-PE (Polyethylene), HDPE (High Density Polyethylene), LDPE (Low Density Polyethylene), -PVC (Polyvinyl Chloride), -ABS (Acrylonitrile Butadiene Styrene...
$ 3800
Cage Free Eggs Comprehensive Study by Application (Food Processing, Food Service), Housing System (Single Tier Aviary, Multi-Tier Aviary, Hybrid Multi-Tier Aviary), Egg Type (White, Brown), Distribut...
$ 3800
Saffron Comprehensive Study by Type (Thread Form, Powder Form, Liquid Form), Application (Food, Medical, Cosmetics), Formulation (Powder, Liquid, Thread), End Use Industry (Retail, Food Service (Rest...
$ 3800